An Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases

被引：889

作者：

Ghany, Marc G. ^{[1
]}

Nelson, David R. ^{[2
]}

Strader, Doris B. ^{[3
]}

Thomas, David L. ^{[4
]}

Seeff, Leonard B. ^{[5
]}

机构：

[1] NIDDK, Liver Dis Branch, NIH, Bethesda, MD 20892 USA

[2] Univ Florida, Sect Hepatobiliary Dis, Gainesville, FL USA

[3] Univ Vermont, Coll Med, Div Gastroenterol & Hepatol, Burlington, VT USA

[4] Johns Hopkins Med Inst, Baltimore, MD 21205 USA

[5] Hill Grp, Bethesda, MD USA

来源：

HEPATOLOGY | 2011年 / 54卷 / 04期

关键词：

SUSTAINED VIROLOGICAL RESPONSE; PEGINTERFERON ALPHA-2A; GENETIC-VARIATION; PLUS RIBAVIRIN; VIRAL RESPONSE; FOLLOW-UP; TELAPREVIR; COMBINATION; IL28B; BOCEPREVIR;

D O I：

10.1002/hep.24641

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：1433 / 1444

页数：12

共 33 条

[1] Amino Acid Substitution in Hepatitis C Virus Core Region and Genetic Variation Near the Interleukin 28B Gene Predict Viral Response to Telaprevir with Peginterferon and Ribavirin [J].

Akuta, Norio ;

Suzuki, Fumitaka ;

Hirakawa, Miharu ;

Kawamura, Yusuke ;

Yatsuji, Hiromi ;

Sezaki, Hitomi ;

Suzuki, Yoshiyuki ;

Hosaka, Tetsuya ;

Kobayashi, Masahiro ;

Kobayashi, Mariko ;

Saitoh, Satoshi ;

Arase, Yasuji ;

Ikeda, Kenji ;

Chayama, Kazuaki ;

Nakamura, Yusuke ;

Kumada, Hiromitsu .

HEPATOLOGY, 2010, 52 (02) :421-429

[2]

[Anonymous], 1995, GASTROENTEROLOGY, V108, P925

[3]

[Anonymous], HIGHLIGHTS PRESCRIBI

[4] Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection [J].

Bacon, Bruce R. ;

Gordon, Stuart C. ;

Lawitz, Eric ;

Marcellin, Patrick ;

Vierling, John M. ;

Zeuzem, Stefan ;

Poordad, Fred ;

Goodman, Zachary D. ;

Sings, Heather L. ;

Poordad, Fred ;

Goodman, Zachary D. ;

Sings, Heather L. ;

Boparai, Navdeep ;

Burroughs, Margaret ;

Brass, Clifford A. ;

Albrecht, Janice K. ;

Esteban, Rafael .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (13) :1207-1217

[5] Sustained Virologic Response Prevents the Development of Esophageal Varices in Compensated, Child-Pugh Class A Hepatitis C Virus-Induced Cirrhosis. A 12-Year Prospective Follow-up Study [J].

Bruno, Savino ;

Crosignani, Andrea ;

Facciotto, Corinna ;

Rossi, Sonia ;

Roffi, Luigi ;

Redaelli, Alessandro ;

de Franchis, Roberto ;

Almasio, Piero Luigi ;

Maisonneuve, Patrick .

HEPATOLOGY, 2010, 51 (06) :2069-2076

[6]

Eddy DM, 1996, MANUAL ASSESSING HLT

[7] ACTIVITY OF TELAPREVIR ALONE OR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 2 AND 3 HEPATITIS-C PATIENTS: INTERIM RESULTS OF STUDY C209 [J].

Foster, G. R. ;

Hezode, C. ;

Bronowicki, J. -P. ;

Carosi, G. ;

Weiland, O. ;

Verlinden, L. ;

van Heeswijk, R. ;

Vangeneugden, T. ;

Picchio, G. ;

Beumont-Mauviel, M. .

JOURNAL OF HEPATOLOGY, 2009, 50 :S22-S22

[8] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. [J].

Fried, MW ;

Shiffman, ML ;

Reddy, KR ;

Smith, C ;

Marinos, G ;

Goncales, FL ;

Haussinger, D ;

Diago, M ;

Carosi, G ;

Dhumeaux, D ;

Craxi, A ;

Lin, A ;

Hoffman, J ;

Yu, J .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13) :975-982

[9] Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance [J].

Ge, Dongliang ;

Fellay, Jacques ;

Thompson, Alexander J. ;

Simon, Jason S. ;

Shianna, Kevin V. ;

Urban, Thomas J. ;

Heinzen, Erin L. ;

Qiu, Ping ;

Bertelsen, Arthur H. ;

Muir, Andrew J. ;

Sulkowski, Mark ;

McHutchison, John G. ;

Goldstein, David B. .

NATURE, 2009, 461 (7262) :399-401

[10] Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C -: A randomized study of treatment duration and ribavirin dose [J].

Hadziyannis, SJ ;

Sette, H ;

Morgan, TR ;

Balan, V ;

Diago, M ;

Marcellin, P ;

Ramadori, G ;

Bodenheimer, H ;

Bernstein, D ;

Rizzetto, M ;

Zeuzem, S ;

Pockros, PJ ;

Lin, A ;

Ackrill, AM .

ANNALS OF INTERNAL MEDICINE, 2004, 140 (05) :346-355

← 1 2 3 4 →